Johnson & Johnson (NYSE:JNJ) Q4 2025 Earnings Call Transcript January 21, 2026 Johnson & Johnson reports earnings inline with expectations. Reported EPS is $2.46 EPS, expectations were $2.46. Operator: Good morning, and welcome to Johnson & …

Our machine-driven multifactor analysis suggests it may be time to sell JNJ stock, as we hold a pessimistic outlook with a potential target price of $134. The company’s Moderate operating performance and financial health, combined with its High valuation, …

Johnson & Johnson (NYSE:JNJ) shares surged 43% in 2025, far outpacing the S&P 500’s 16% gain and delivering the company’s strongest annual performance since 1995. Analysts expect fourth-quarter adjusted earnings of $2.42 per share on sales of $24.1 …

Johnson & Johnson JNJ is set to release its second-quarter earnings on Wednesday, July 16. According to Benzinga Pro data, analysts estimate adjusted earnings of $2.68 per share and sales of $22.85 billion. While overall estimates for 2025 and beyond …

Johnson & Johnson (NYSE:JNJ) Q1 2025 Earnings Call Transcript April 15, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, expectations were $2.58. Operator: Good morning, and welcome to Johnson & Johnson’s First Quarter …

Johnson & Johnson JNJ, on Tuesday, reported a first-quarter 2025 adjusted EPS of $2.77, up 2.2% year over year, beating the consensus of $2.60. The pharmaceutical giant reported sales of $21.89 billion, up 2.4% year over year and beating the consensus  …

Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2025. “The power of Johnson & Johnson’s uniquely diversified portfolio was on full display this quarter, with strong operational sales growth reinforcing our confidence in 2025 …

Johnson & Johnson's JNJ Janssen Biotech has filed a lawsuit against Samsung Bioepis, alleging the company violated a settlement agreement regarding selling a biosimilar version of Stelara, a widely used treatment for autoimmune diseases. Janssen …

Johnson & Johnson (NYSE:JNJ) Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, expectations were $1.99. Operator: Good morning and welcome to Johnson & Johnson’s Fourth …

Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2024. "2024 was a transformative year for Johnson & Johnson, marked by strong growth, an accelerating pipeline and industry-leading investments in …